July 06, 2020

CSRWire.com The Corporate Social Responsibility Newswire

news by category

CSR News

Bayer to Donate EUR 1 Million to Support the Fight Against COVID-19 in Brazil

Support for projects of the Brazilian government, the national health system and UNICEF

Submitted by: Bayer

Categories: Health & Wellness, Philanthropy & Corporate Contributions

Posted: Apr 24, 2020 – 12:04 PM EST

 

LEVERKUSEN, Apr. 24 /CSRwire/ - Bayer will donate EUR 1 million (R$ 5.7 million) to help combat the coronavirus pandemic in Brazil.

Approximately EUR 490,000 (R$ 2.8 million) is being contributed to the Brazilian government’s “Solidaric Fundraising” campaign to finance various projects for the prevention, diagnosis and treatment of COVID-19. Around EUR 350,000 (R$ 2 million) will go to UNICEF in Brazil to support children, youth projects and underprivileged communities. Another approximately EUR 160,000 (R$ 900,000) will enable the national health system to purchase face masks, protective gear and equipment for hospitals.

“The crisis caused by the COVID-19 pandemic challenges all of us. The collaboration between the public and private sectors and civil society will be crucial to overcome these challenges,” said Marc Reichardt, Senior Bayer Representative in Brazil. “Our contribution goes far beyond financial support. Our employees are working around the clock to maintain the availability of medicines and food in Brazil.”

Bayer is supporting the worldwide fight against the corona pandemic with its products, technical equipment, know-how and the engagement of its employees. You can find a current overview here: https://www.bayer.com/en/coronavirus-covid-19-update.aspx.

A digital press kit is available at: https://www.media.bayer.com/baynews/baynews.nsf/id/presskit-corona

More information about the “All united against the virus” alliance can be found at: https://www.fondationdefrance.org/fr/tous-unis-contre-le-virus-la-fondation-de-france-lap-hp-et-linstitut-pasteur-lancent-un-appel-la

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.

Follow us on Twitter: twitter.com/Bayer

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

For more information, please contact:

There is currently no contact information.

For more from this organization:

Bayer

 

Issuers of news releases and not csrwire are solely responsible for the accuracy of the content